DNABW Ginkgo Bioworks Holdings, Inc.
Fundamentals / CIK 0001830214 / USDGinkgo Bioworks Holdings, Inc. reported $130.8M in revenue and a net loss of $251.0M for the trailing twelve months ended September 30, 2026 (down 5.7% year over year), with a -204.5% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DNABW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$130.8M -5.7% YoY
-
Operating Income TTM-$267.4M -204.5% margin
-
Net Income TTM-$251.0M -192.0% net margin
-
Diluted EPS TTM-$5.64 Split-adjusted
-
Free Cash Flow TTM-$173.5M -132.7% FCF margin
-
Cash & ST Investments Sep 30, 2026$84.50M Total debt: $397.2M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $170.2M | $227.0M | $251.5M | $477.7M | $313.8M | $76.66M | $54.18M |
| Research & Development | $243.8M | $424.1M | $580.6M | $1.05B | $1.15B | $159.8M | $96.30M |
| Total Operating Expenses | $485.4M | $786.8M | $1.12B | $2.69B | $2.14B | $213.7M | $125.8M |
| Operating Income | -$315.3M | -$559.8M | -$864.4M | -$2.21B | -$1.83B | -$137.0M | -$71.60M |
| EBITDA | -$256.3M | -$496.7M | -$793.9M | -$2.17B | -$1.80B | -$123.2M | -$60.84M |
| Interest Income | $22.62M | $38.61M | $57.22M | $20.26M | $837K | $2.58M | $5.76M |
| Interest Expense | $0 | $94K | $93K | $106K | $2.37M | $2.38M | $2.42M |
| Income Before Tax | -$313.6M | -$547.5M | -$892.9M | -$2.12B | -$1.84B | -$124.8M | -$119.8M |
| Income Tax Expense | -$837K | -$479K | -$71K | -$15.03M | -$1.48M | $1.89M | $22K |
| Net Income | -$312.8M | -$547.0M | -$892.9M | -$2.10B | -$1.83B | -$126.6M | -$119.3M |
| Basic EPS | -$5.64 | -$10.54 | -$18.37 | -$50.15 | -$54.00 | -$4.00 | -$4.00 |
| Diluted EPS | -$5.64 | -$10.54 | -$18.37 | -$50.20 | -$55.60 | -$4.00 | -$4.00 |
| Basic Shares Outstanding | 55.5M | 51.9M | 48.6M | 42.0M | 34.0M | 31.9M | 28.7M |
| Diluted Shares Outstanding | 55.5M | 51.9M | 48.6M | 42.0M | 34.0M | 31.9M | 28.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.71M | $20.16M | $19.47M | $63.41M | $29.38M | $39.13M | $38.23M | $43.85M |
| Cost of Revenue | $1.81M | $1.72M | $3.10M | -- | $4.62M | $5.38M | $4.09M | -- |
| Gross Profit | $25.91M | $18.44M | $16.38M | -- | $24.75M | $33.75M | $34.14M | -- |
| Research & Development | $40.95M | $46.21M | $49.92M | $50.13M | $69.35M | $53.37M | $70.92M | $76.38M |
| Total Operating Expenses | -- | -- | -- | $104.1M | $128.9M | $115.1M | $137.3M | $147.5M |
| Operating Income | -$43.63M | -$58.55M | -$71.37M | -$93.84M | -$82.31M | -$58.16M | -$80.97M | -$103.6M |
| EBITDA | -$31.59M | -$46.23M | -$58.58M | -$78.54M | -$68.68M | -$42.91M | -$66.15M | -$87.95M |
| Income Before Tax | -$41.26M | -$57.19M | -$76.14M | -$103.5M | -$73.35M | -$53.48M | -$83.22M | -$107.9M |
| Income Tax Expense | -$271K | $128K | -$80K | -$643K | $1.0K | -$283K | $88K | -$325K |
| Net Income | -$40.98M | -$46.71M | -$82.59M | -$80.75M | -$80.75M | -$60.30M | -$90.96M | -- |
| Basic EPS | -$0.64 | -$0.75 | -$1.39 | -- | -$1.45 | -$1.10 | -$1.68 | -- |
| Diluted EPS | -- | -- | -- | -- | -$1.45 | -$1.10 | -$1.68 | -- |
| Basic Shares Outstanding | 64.0M | 62.1M | 59.6M | -- | 55.6M | 54.9M | 54.2M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 55.6M | 54.9M | 54.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $167.2M | $561.6M | $944.1M | $1.32B | $1.55B | $380.8M |
| Short-Term Investments | $255.4M | $0 | -- | -- | -- | -- |
| Cash & Short-Term Investments | $422.6M | $561.6M | $944.1M | $1.32B | $1.55B | $380.8M |
| Accounts Receivable, Net | $24.03M | $21.86M | $17.16M | $80.91M | $131.5M | $16.69M |
| Inventory | -- | -- | $46K | $4.36M | $3.36M | $2.74M |
| Other Current Assets | -- | -- | $362K | $487K | $698K | $680K |
| Total Current Assets | $471.8M | $602.7M | $1.00B | $1.45B | $1.72B | $426.5M |
| Property, Plant & Equipment, Net | $167.4M | $203.7M | $188.2M | $314.8M | $145.8M | $121.4M |
| Goodwill | -- | $0 | $49.24M | $60.21M | $21.31M | $1.86M |
| Intangible Assets | $53.48M | $72.51M | $82.74M | $111.0M | $21.64M | $3.29M |
| Other Non-Current Assets | $9.03M | $55.34M | $58.05M | $88.72M | $43.99M | $5.60M |
| Total Non-Current Assets | $647.9M | $774.7M | $663.6M | $1.09B | $347.9M | $248.6M |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675.2M |
| Accounts Payable | $10.57M | $14.17M | $9.32M | $10.45M | $8.19M | $13.89M |
| Deferred Revenue (Current) | $18.95M | $27.71M | $44.49M | $47.82M | $33.24M | $28.82M |
| Total Current Liabilities | $95.97M | $107.3M | $163.9M | $173.0M | $134.8M | $73.22M |
| Deferred Revenue (Non-Current) | $75.18M | $98.78M | $158.1M | $174.8M | $156.0M | $99.65M |
| Other Non-Current Liabilities | $22.88M | $16.58M | $24.43M | $31.19M | $35.99M | $3.03M |
| Total Non-Current Liabilities | $515.1M | $554.1M | $404.3M | $630.1M | $368.9M | $131.9M |
| Total Liabilities | $611.1M | $661.4M | $568.2M | $803.0M | $503.6M | $205.1M |
| Total Debt (incl. Leases) | $439.9M | $467.8M | $242.2M | $444.1M | $22.28M | $16.52M |
| Common Stock | $6.0K | $5.0K | $5.0K | $190K | $161K | $129K |
| Retained Earnings | -$6.15B | -$5.84B | -$5.29B | -$4.40B | -$2.30B | -$467.9M |
| Accumulated Other Comp. Income | $1.85M | -$1.81M | $1.48M | -$2.63M | -$1.72M | $0 |
| Total Stockholders' Equity | $508.6M | $716.1M | $1.10B | $1.74B | $1.51B | $461.4M |
| Total Equity | $508.6M | $716.1M | $1.10B | $1.74B | $1.57B | $470.1M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $84.50M | $84.53M | $143.9M | $167.2M | $111.1M | $203.6M | $312.4M | $561.6M |
| Short-Term Investments | -- | -- | -- | $255.4M | $384.4M | $355.8M | $12.84M | $0 |
| Cash & Short-Term Investments | $84.50M | $84.53M | $143.9M | $422.6M | $495.5M | $559.4M | $325.3M | $561.6M |
| Accounts Receivable, Net | $11.48M | $13.01M | $19.82M | $24.03M | $21.43M | $22.15M | $26.29M | $21.86M |
| Total Current Assets | $310.8M | $332.5M | $410.0M | $471.8M | $506.1M | $523.0M | $564.5M | $602.7M |
| Property, Plant & Equipment, Net | $152.3M | $157.2M | $163.0M | $167.4M | $176.6M | $186.4M | $197.8M | $203.7M |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $0 |
| Intangible Assets | $39.73M | $44.39M | $48.86M | $53.48M | $61.52M | $66.15M | $68.76M | $72.51M |
| Other Non-Current Assets | $1.25M | $1.32M | $39.52M | $9.03M | $46.59M | $47.02M | $46.78M | $55.34M |
| Total Non-Current Assets | $633.6M | $657.5M | $623.1M | $647.9M | $683.1M | $708.0M | $728.9M | $774.7M |
| Total Assets | $944.5M | $990.0M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B |
| Accounts Payable | $7.18M | $9.57M | $16.31M | $10.57M | $10.70M | $11.20M | $11.27M | $14.17M |
| Deferred Revenue (Current) | $6.39M | $13.21M | $14.91M | $18.95M | $25.24M | $28.29M | $33.65M | $27.71M |
| Total Current Liabilities | $65.85M | $72.74M | $79.59M | $95.97M | $115.3M | $96.72M | $115.7M | $107.3M |
| Deferred Revenue (Non-Current) | $71.98M | $76.54M | $77.89M | $75.18M | $74.07M | $74.57M | $80.38M | $98.78M |
| Other Non-Current Liabilities | $16.79M | $16.37M | $21.73M | $22.88M | $17.16M | $17.94M | $15.43M | $16.58M |
| Total Non-Current Liabilities | $486.0M | $497.0M | $510.3M | $515.1M | $514.1M | $521.3M | $530.4M | $554.1M |
| Total Liabilities | $551.8M | $569.8M | $589.9M | $611.1M | $629.4M | $618.1M | $646.0M | $661.4M |
| Total Debt (incl. Leases) | $397.2M | $404.1M | $410.7M | $439.9M | $422.9M | $428.8M | $434.6M | $467.8M |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K |
| Retained Earnings | -$6.32B | -$6.28B | -$6.23B | -$6.15B | -$6.07B | -$5.99B | -$5.93B | -$5.84B |
| Accumulated Other Comp. Income | $115K | $950K | $1.19M | $1.85M | $2.00M | $1.65M | -$850K | -$1.81M |
| Total Stockholders' Equity | $392.6M | $420.3M | $443.2M | $508.6M | $559.8M | $613.0M | $647.4M | $716.1M |
| Total Equity | $392.6M | $420.3M | $443.2M | $508.6M | $559.8M | $613.0M | $647.4M | $716.1M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$312.8M | -$547.0M | -$892.9M | -$2.11B | -$1.84B | -$126.7M | -$119.9M |
| Depreciation & Amortization | $58.99M | $63.02M | $70.51M | $42.55M | $29.08M | $13.86M | $10.76M |
| Stock-Based Compensation | $81.55M | $112.3M | $229.9M | $1.93B | $1.61B | $476K | $771K |
| Change in Receivables | -$1.47M | -$4.72M | $50.07M | $55.02M | -$114.1M | -$14.23M | -$1.84M |
| Change in Inventory | -- | -- | -- | $164K | -$626K | -$2.74M | -- |
| Change in Payables | -$2.99M | $4.77M | -$1.18M | -$10.84M | -$2.25M | $7.02M | $664K |
| Operating Cash Flow | -$171.1M | -$319.6M | -$295.5M | -$252.2M | -$253.8M | -$135.8M | -$44.66M |
| Capital Expenditure | -$7.67M | -$62.54M | -$40.80M | -$52.27M | -$56.52M | -$57.82M | -$22.22M |
| Free Cash Flow | -$178.7M | -$382.1M | -$336.3M | -$304.5M | -$310.3M | -$193.7M | -$66.88M |
| Acquisitions, Net | $0 | -$5.40M | $0 | $82.37M | -$12.04M | $0 | -- |
| Purchases of Investments | -$418.6M | $0 | $0 | -- | -- | -- | -- |
| Sales & Maturities of Investments | $185.4M | $0 | $0 | -- | -- | -- | -- |
| Investing Cash Flow | -$240.3M | -$62.24M | -$80.69M | -$67.39M | -$73.26M | -$67.12M | -$74.60M |
| Common Stock Issued | $19.47M | $0 | $0 | $40.38M | $15.09M | $0 | -- |
| Share Repurchases | -- | -- | $0 | $0 | -$25.00M | $0 | -$408K |
| Financing Cash Flow | $17.77M | -$1.74M | -$3.22M | $95.34M | $1.53B | $90.32M | $410.4M |
| Net Change in Cash | -$393.4M | -$383.8M | -$380.0M | -$223.3M | $1.21B | -$112.6M | $291.1M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$40.98M | -$46.71M | -$82.59M | -$80.75M | -$80.75M | -$60.30M | -$90.96M | -- |
| Depreciation & Amortization | $12.04M | $12.31M | $12.80M | $15.29M | $13.62M | $15.25M | $14.82M | $15.65M |
| Stock-Based Compensation | $7.67M | $7.59M | $15.85M | $30.32M | $15.04M | $18.80M | $17.39M | $20.56M |
| Change in Receivables | $1.50M | $3.71M | -$242K | -$2.92M | -$750K | $2.87M | -$667K | $1.38M |
| Operating Cash Flow | -$28.35M | -$44.27M | -$46.69M | -$47.68M | -$31.61M | -$40.25M | -$51.52M | -$42.44M |
| Capital Expenditure | -$2.00M | -$2.62M | -$1.93M | -$5.0K | $0 | -$38K | -$7.62M | -$13.71M |
| Free Cash Flow | -$30.35M | -$46.89M | -$48.62M | -$47.68M | -$31.61M | -$40.29M | -$59.14M | -$56.15M |
| Acquisitions, Net | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$89.36M | -$44.28M | -$83.16M | -$16.79M | -$81.71M | -$128.9M | -$191.2M | $0 |
| Investing Cash Flow | -$24.10M | $11.09M | $23.13M | $95.10M | -$72.82M | -$63.89M | -$198.7M | -$13.09M |
| Financing Cash Flow | $6.50M | $16.49M | -$19K | $8.14M | $9.94M | -$98K | -$207K | -$203K |
| Net Change in Cash | -$45.94M | -$16.65M | -$23.70M | $55.41M | -$94.39M | -$104.1M | -$250.3M | -$55.80M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | -582.6% | -178.8% | -132.1% |
| Net Profit Margin | -183.8% | -240.9% | -355.1% | -440.6% | -583.1% | -165.2% | -220.2% |
| Return on Equity (ROE) | -61.5% | -76.4% | -81.4% | -121.2% | -121.6% | -27.4% | -- |
| Return on Assets (ROA) | -27.9% | -39.7% | -53.6% | -82.9% | -88.4% | -18.8% | -- |
| Current Ratio | 4.92x | 5.62x | 6.11x | 8.38x | 12.79x | 5.83x | -- |
| Quick Ratio | 4.65x | 5.44x | 6.11x | 8.36x | 12.76x | 5.79x | -- |
| Debt to Equity | 0.86x | 0.65x | 0.22x | 0.26x | 0.01x | 0.04x | -- |
| Revenue Growth (YoY) | -25.1% | -9.7% | -47.4% | +52.2% | +309.4% | +41.5% | -- |
| 5Y Revenue / Share Growth | +27.6% | +131.9% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -204.5% | -231.1% | -201.9% | -185.3% | -215.8% | -141.7% | -203.5% | -246.5% |
| Net Profit Margin | -192.0% | -219.6% | -201.1% | -183.8% | -- | -- | -- | -- |
| Return on Equity (ROE) | -63.9% | -69.2% | -68.7% | -61.5% | -- | -- | -- | -- |
| Return on Assets (ROA) | -26.6% | -29.4% | -29.5% | -27.9% | -- | -- | -- | -- |
| Current Ratio | 4.72x | 4.57x | 5.15x | 4.92x | 4.39x | 5.41x | 4.88x | 5.62x |
| Quick Ratio | 1.46x | 1.34x | 2.06x | 4.65x | 4.48x | 6.01x | 3.04x | 5.44x |
| Debt to Equity | 1.01x | 0.96x | 0.93x | 0.86x | 0.76x | 0.70x | 0.67x | 0.65x |
| Revenue Growth (YoY) | -5.7% | -48.5% | -49.1% | +44.6% | -67.0% | -30.4% | +0.8% | +26.2% |
| Gross Profit Growth (YoY) | +4.6% | -45.4% | -52.0% | -- | -- | -- | -- | -- |